Concepedia

Publication | Open Access

Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia

DOIFull Paper Access

165

Citations

31

References

2012

Year

Tait D. Shanafelt, Timothy G. Call, Clive S. Zent, José F. Leis, Betsy LaPlant, Deborah A. Bowen, Michelle Roos, Kristina Laumann, Asish K. Ghosh, Connie Lesnick,
Cancer

Abstract

Daily oral EGCG in the Polyphenon E preparation was well tolerated by patients with CLL in this phase 2 trial. Durable declines in the ALC and/or lymphadenopathy were observed in the majority of patients.

References

YearCitations

Page 1